Raporty finansowe: Rachunek zysków i strat
BAY (BAYER)
122.00+10.86(+9.77%)
BAYER AG
TENDENCJE POZYTYWNE
Zysk operacyjny (EBIT): wzrost o 73.79% r/r |
Zysk przed opodatkowaniem: wzrost o 134.21% r/r |
Zysk netto: wzrost o 553.60% r/r |
TENDENCJE NEGATYWNE
Przychody ze sprzedaży: spadek o 5.08% r/r |
Zysk ze sprzedaży: spadek o 20.46% r/r |
EBITDA: spadek o 14.41% r/r |
2011/Q2 (cze 11) | 2012/Q2 (cze 12) | 2013/Q2 (cze 13) | 2014/Q2 (cze 14) | 2015/Q2 (cze 15) | 2016/Q2 (cze 16) | 2017/Q2 (cze 17) | 2018/Q2 (cze 18) | 2019/Q2 (cze 19) | 2020/Q2 (cze 20) | 2021/Q2 (cze 21) | 2022/Q2 (cze 22) | 2023/Q2 (cze 23) | 2024/Q2 (cze 24) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Data publikacji | 2011-07-28 | 2012-07-31 | 2013-07-31 | 2014-07-30 | 2015-07-29 | 2016-07-28 | 2017-07-27 | 2018-09-05 | 2019-07-30 | 2020-08-04 | 2021-08-05 | 2022-08-04 | 2023-08-08 | 2024-08-06 | |
Przychody ze sprzedaży | 74 417 862 k/k +97.02% | 86 163 486 r/r +15.78% k/k +105.93% | 89 294 079 r/r +3.63% k/k +108.22% | 85 631 322 r/r -4.10% k/k +94.49% | 100 535 574 r/r +17.41% k/k +102.91% | 104 826 819 r/r +4.27% k/k +105.67% | 107 509 481 r/r +2.56% k/k +92.37% | 81 208 630 r/r -24.46% k/k +111.17% | 104 174 000 r/r +28.28% k/k +86.09% | 102 266 934 r/r -1.83% k/k +74.89% | 104 801 186 r/r +2.48% k/k +82.41% | 128 519 915 r/r +22.63% k/k +88.70% | 113 184 480 r/r -11.93% k/k +68.24% | 107 432 517 r/r -5.08% k/k +81.47% | |
Techniczny koszt wytworzenia produkcji sprzedanej | 35 700 003 k/k +100.55% | 40 891 435 r/r +14.54% k/k +106.64% | 42 170 737 r/r +3.13% k/k +110.18% | 40 464 753 r/r -4.05% k/k +101.47% | 45 249 187 r/r +11.82% k/k +98.82% | 44 573 636 r/r -1.49% k/k +105.32% | 44 226 096 r/r -0.78% k/k +96.08% | 28 005 834 r/r -36.68% k/k +128.76% | 41 053 060 r/r +46.59% k/k +81.59% | 38 738 084 r/r -5.64% k/k +82.77% | 41 790 275 r/r +7.88% k/k +90.87% | 50 812 594 r/r +21.59% k/k +111.00% | 46 510 085 r/r -8.47% k/k +73.52% | 45 101 041 r/r -3.03% k/k +91.95% | |
Koszty sprzedaży | 17 449 348 k/k +102.58% | 20 492 592 r/r +17.44% k/k +114.56% | 22 117 883 r/r +7.93% k/k +117.26% | 20 471 628 r/r -7.44% k/k +100.89% | 25 573 257 r/r +24.92% k/k +108.13% | 26 464 490 r/r +3.49% k/k +112.77% | 26 153 582 r/r -1.17% k/k +105.70% | 23 766 358 r/r -9.13% k/k +125.08% | 27 842 096 r/r +17.15% k/k +113.21% | 26 483 380 r/r -4.88% k/k +92.44% | 26 415 034 r/r -0.26% k/k +96.88% | 32 857 812 r/r +24.39% k/k +115.05% | 29 327 477 r/r -10.74% k/k +84.81% | 28 495 991 r/r -2.84% k/k +104.18% | |
Koszty ogólnego zarządu | 9 228 979 k/k +98.14% | 10 060 929 r/r +9.01% k/k +111.14% | 10 472 335 r/r +4.09% k/k +111.02% | 10 352 319 r/r -1.15% k/k +100.63% | 12 595 783 r/r +21.67% k/k +114.07% | 14 227 983 r/r +12.96% k/k +107.43% | 14 805 430 r/r +4.06% k/k +102.81% | 14 397 642 r/r -2.75% k/k +133.20% | 20 456 372 r/r +42.08% k/k +88.35% | 18 096 232 r/r -11.54% k/k +87.86% | 19 263 129 r/r +6.45% k/k +124.64% | 22 368 587 r/r +16.12% k/k +127.32% | 17 560 884 r/r -21.49% k/k +68.50% | 5 481 823 r/r -68.78% k/k +118.62% | |
Zysk ze sprzedaży | 12 039 532 k/k +79.70% | 14 718 530 r/r +22.25% k/k +90.25% | 14 533 124 r/r -1.26% k/k +89.28% | 14 342 622 r/r -1.31% k/k +66.91% | 17 117 346 r/r +19.35% k/k +98.68% | 19 560 710 r/r +14.27% k/k +96.34% | 22 324 373 r/r +14.13% k/k +67.63% | 15 038 797 r/r -32.64% k/k +58.61% | 14 822 472 r/r -1.44% k/k +56.78% | 18 949 238 r/r +27.84% k/k +36.48% | 17 332 747 r/r -8.53% k/k +27.76% | 22 480 922 r/r +29.70% k/k +18.90% | 19 786 034 r/r -11.99% k/k +39.53% | 15 738 137 r/r -20.46% k/k +20.05% | |
Pozostałe przychody operacyjne | 1 917 555 k/k +87.44% | 1 214 471 r/r -36.67% k/k +79.04% | 1 969 786 r/r +62.19% k/k +192.88% | 865 467 r/r -56.06% k/k +60.84% | 1 166 043 r/r +34.73% k/k +10.10% | 1 602 031 r/r +37.39% k/k +84.89% | 1 885 019 r/r +17.66% k/k +155.26% | 1 469 859 r/r -22.02% k/k +129.78% | 2 040 960 r/r +38.85% k/k +254.10% | 3 224 452 r/r +57.99% k/k +67.45% | 4 009 950 r/r +24.36% k/k +145.84% | 6 033 293 r/r +50.46% k/k +154.77% | 4 441 399 r/r -26.39% k/k +147.38% | 3 415 896 r/r -23.09% k/k +195.25% | |
Pozostałe koszty operacyjne | 4 305 528 k/k +38.12% | 5 829 458 r/r +35.39% k/k +258.25% | 3 264 217 r/r -44.00% k/k +242.72% | 644 940 r/r -80.24% k/k +66.25% | 2 441 141 r/r +278.51% k/k +62.23% | 1 433 862 r/r -41.26% k/k +66.30% | 1 948 417 r/r +35.89% k/k +114.76% | 540 838 r/r -72.24% k/k +35.27% | 4 634 680 r/r +756.94% k/k +182.07% | 59 174 500 r/r +1176.78% k/k +1234.58% | 17 717 015 r/r -70.06% k/k +2035.78% | 8 008 507 r/r -54.80% k/k +376.82% | 15 251 178 r/r +90.44% k/k +634.67% | 3 553 912 r/r -76.70% k/k +267.25% | |
Zysk operacyjny (EBIT) | 9 651 559 k/k +109.56% | 10 103 542 r/r +4.68% k/k +48.85% | 13 238 694 r/r +31.03% k/k +78.95% | 14 563 150 r/r +10.00% k/k +66.57% | 15 842 249 r/r +8.78% k/k +93.91% | 19 728 879 r/r +24.53% k/k +97.95% | 22 260 976 r/r +12.83% k/k +69.30% | 15 967 818 r/r -28.27% k/k +64.25% | 12 228 752 r/r -23.42% k/k +45.80% | -37 000 810 r/r -402.57% k/k -425.25% | 3 625 682 r/r +109.80% k/k -74.77% | 20 505 709 r/r +465.57% k/k +4.64% | 8 976 255 r/r -56.23% k/k -35.42% | 15 600 121 r/r +73.79% k/k +17.31% | |
Przychody finansowe | 932 864 k/k +374.54% | 1 044 019 r/r +11.92% k/k +126.01% | 718 647 r/r -31.17% k/k +149.32% | 790 571 r/r +10.01% k/k +106.01% | 406 857 r/r -48.54% k/k +729.17% | 349 615 r/r -14.07% k/k +121.37% | 574 804 r/r +64.41% k/k +289.19% | 2 311 648 r/r +302.16% k/k +48.45% | 1 011 976 r/r -56.22% k/k +38.40% | 357 280 r/r -64.69% k/k +118.01% | 1 668 175 r/r +366.91% k/k +265.26% | 547 630 r/r -67.17% k/k +75.68% | 943 464 r/r +72.28% k/k +36.34% | 1 104 128 r/r +17.03% k/k +59.45% | |
Koszty finansowe | 2 380 000 k/k +136.35% | 2 701 664 r/r +13.52% k/k +121.57% | 2 480 632 r/r -8.18% k/k +134.71% | 2 138 703 r/r -13.78% k/k +108.42% | 2 759 915 r/r +29.05% k/k +131.15% | 3 084 574 r/r +11.76% k/k +108.26% | 3 660 149 r/r +18.66% k/k +133.79% | 3 576 512 r/r -2.29% k/k +173.26% | 4 226 488 r/r +18.17% k/k +110.41% | 4 394 544 r/r +3.98% k/k +41.96% | 4 046 116 r/r -7.93% k/k +106.72% | 5 803 944 r/r +43.44% k/k +132.31% | 4 962 085 r/r -14.50% k/k +122.03% | 5 736 290 r/r +15.60% k/k +105.82% | |
Pozostałe przychody (koszty) | -83 719 k/k -89.71% | -46 874 r/r +44.01% k/k -87.73% | -34 634 r/r +26.11% k/k -38.18% | -33 287 r/r +3.89% k/k -59.60% | 0 r/r +100.00% k/k -100.00% | -48 681 k/k -128.10% | -101 436 r/r -108.37% k/k -84.91% | 427 437 r/r +521.39% k/k +43.05% | -157 324 r/r -136.81% k/k -92.50% | -107 184 r/r +31.87% k/k -194.31% | 357 143 r/r +433.21% k/k +394.75% | -276 155 r/r -177.32% k/k -196.78% | -364 925 r/r -32.14% k/k -110.95% | -211 337 r/r +42.09% k/k -250.98% | |
Zysk z działalności gospodarczej | 8 120 704 k/k +116.49% | 8 399 022 r/r +3.43% k/k +39.86% | 11 442 076 r/r +36.23% k/k +73.25% | 13 181 731 r/r +15.20% k/k +63.14% | 13 489 190 r/r +2.33% k/k +91.35% | 16 945 240 r/r +25.62% k/k +96.53% | 19 074 195 r/r +12.56% k/k +63.36% | 15 130 390 r/r -20.68% k/k +47.34% | 8 856 916 r/r -41.46% k/k +26.02% | -41 145 258 r/r -564.56% k/k -589.35% | 1 604 884 r/r +103.90% k/k -87.41% | 14 973 239 r/r +832.98% k/k -13.53% | 4 592 710 r/r -69.33% k/k -62.31% | 10 756 622 r/r +134.21% k/k -3.47% | |
Wynik zdarzeń nadzwyczajnych | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Zysk przed opodatkowaniem | 8 120 704 k/k +116.49% | 8 399 022 r/r +3.43% k/k +39.86% | 11 442 076 r/r +36.23% k/k +73.25% | 13 181 731 r/r +15.20% k/k +63.14% | 13 489 190 r/r +2.33% k/k +91.35% | 16 945 240 r/r +25.62% k/k +96.53% | 19 074 195 r/r +12.56% k/k +63.36% | 15 130 390 r/r -20.68% k/k +47.34% | 8 856 916 r/r -41.46% k/k +26.02% | -41 145 258 r/r -564.56% k/k -589.35% | 1 604 884 r/r +103.90% k/k -87.41% | 14 973 239 r/r +832.98% k/k -13.53% | 4 592 710 r/r -69.33% k/k -62.31% | 10 756 622 r/r +134.21% k/k -3.47% | |
Zysk (strata) netto z działalności zaniechanej | 0 | 0 | 0 | 262 137 | 260 053 r/r -0.79% | 469 103 r/r +80.39% k/k +181.80% | 1 043 946 r/r +122.54% k/k +149.89% | 26 170 r/r -97.49% k/k -22.27% | 0 r/r -100.00% | 853 006 k/k +56.15% | 0 r/r -100.00% | 0 | 0 | 0 | |
Zysk netto | 5 696 851 k/k +107.90% | 6 507 005 r/r +14.22% k/k +50.20% | 8 684 375 r/r +33.46% k/k +78.91% | 9 902 942 r/r +14.03% k/k +66.60% | 10 347 585 r/r +4.49% k/k +93.32% | 13 404 840 r/r +29.55% k/k +98.64% | 15 840 922 r/r +18.17% k/k +65.30% | 12 033 654 r/r -24.03% k/k +46.33% | 6 998 792 r/r -41.84% k/k +31.65% | -35 955 766 r/r -613.74% k/k -630.80% | -1 075 950 r/r +97.01% k/k -111.05% | 14 065 203 r/r +1407.24% k/k -8.22% | 1 303 938 r/r -90.73% k/k -87.22% | 8 522 488 r/r +553.60% k/k -1.02% | |
Zysk netto akcjonariuszy jednostki dominującej | 5 704 825 k/k +107.89% | 6 481 437 r/r +13.61% k/k +49.75% | 8 662 729 r/r +33.65% k/k +78.77% | 9 886 298 r/r +14.12% k/k +66.55% | 10 297 252 r/r +4.16% k/k +93.27% | 12 794 121 r/r +24.25% k/k +98.37% | 13 977 036 r/r +9.25% k/k +59.01% | 12 007 485 r/r -14.09% k/k +46.02% | 6 994 540 r/r -41.75% k/k +31.04% | -35 991 494 r/r -614.57% k/k -630.98% | -1 112 117 r/r +96.91% k/k -111.42% | 14 009 036 r/r +1359.67% k/k -8.51% | 1 295 037 r/r -90.76% k/k -87.28% | 8 479 358 r/r +554.76% k/k -1.42% | |
EBITDA | 15 037 455 k/k +100.87% | 16 772 477 r/r +11.54% k/k +69.48% | 19 490 058 r/r +16.20% k/k +93.11% | 20 159 561 r/r +3.44% k/k +76.06% | 22 620 399 r/r +12.21% k/k +97.29% | 27 929 331 r/r +23.47% k/k +93.82% | 28 862 769 r/r +3.34% k/k +77.84% | 21 088 336 r/r -26.94% k/k +77.82% | 23 913 248 r/r +13.40% k/k +77.17% | -26 027 848 r/r -208.84% k/k -251.42% | 14 819 182 r/r +156.94% k/k -23.73% | 37 178 006 r/r +150.88% k/k +51.00% | 29 590 045 r/r -20.41% k/k +46.57% | 25 325 936 r/r -14.41% k/k +40.04% |
Dane kwartalne RZiS oraz CashFlow obliczne są na podstawie publikowanych danych skumulowanych.
Dynamika zmian dla sektora obliczana jest w oparciu o medianę.
Dane w tys. PLN
Informacje
ISIN: | DE000BAY0017 |
---|---|
Liczba akcji: | 826 950 000 |
Kapitalizacja: | 100 887 900 000 |
Enterprise Value: | 285 009 870 000 |
Branża: | Produkcja leków |
Bayer AG to firma naukowo-medyczna. Segmenty Spółki to: farmaceutyki, zdrowie konsumentów, uprawa roślin i zdrowie zwierząt. Segment Pharmaceuticals... Bayer AG to firma naukowo-medyczna. Segmenty Spółki to: farmaceutyki, zdrowie konsumentów, uprawa roślin i zdrowie zwierząt. Segment Pharmaceuticals koncentruje się na badaniach, opracowywaniu i sprzedaży produktów na receptę i specjalistycznych terapii, szczególnie w dziedzinie kardiologii, onkologii, ginekologii, hematologii i okulistyki, a także radiofarmakologii i innych. Segment Consumer Health opracowuje, produkuje i sprzedaje bez recepty produkty dostępne bez recepty w zakresie m.in. dermatologii, suplementów diety, leków przeciwbólowych, przewodu pokarmowego, przeziębienia, alergii, zatok i grypy, pielęgnacji stóp i ochrony przeciwsłonecznej. Segment Crop Science bada, rozwija i wprowadza na rynek rozwiązania i nasiona do ochrony roślin, a także obejmuje spółkę zależną Monsanto. Segment Animal Health zajmuje się opracowywaniem, produkcją i marketingiem weterynaryjnych produktów na receptę i bez recepty.
Nazwa: | BAYER AG |
---|---|
Adres: | Werk Leverkusen, 51-368, Leverkusen, Deutschland |
CEO: | Bill Anderson |
Telefon: | +49 (0) 214 30-1 |
WWW: | http://www.bayer.com/ |